Navigation Links
Study Suggests Vitamin D Screening and Appropriate Supplementation Indicated for All Cancer Patients
Date:6/15/2009

CHICAGO, June 15 /PRNewswire-USNewswire/ -- Vitamin D deficiency was found to be prevalent in cancer patients regardless of nutritional status, according to the results of a recent study conducted at Cancer Treatment Centers of America (CTCA). Based on these results, CTCA researchers determined that screening for vitamin D deficiency and aggressive vitamin D repletion should be considered for all people with cancer.

(Logo: http://www.newscom.com/cgi-bin/prnh/20090612/CTCALOGO)

"While emerging evidence suggests the protective role of vitamin D in cancer, vitamin D status is not routinely assessed in cancer patients despite the high prevalence of malnutrition in this population," said Carolyn Lammersfeld, national director of nutrition for CTCA and a principal investigator in the study.

During the study, a consecutive case series of 737 cancer patients (302 male and 435 female) seen at CTCA between January - June 2008, were assessed for nutritional status and categorizes into three distinct classes of nutritional status: well nourished, moderately malnourished and severely malnourished. The mean age at presentation was 55.7 years (SD = 10.2) and the most common cancer types were lung (133, 18%), breast (131, 17.8%), colorectal (97, 13.2%), pancreatic (86, 11.7%), prostate (44, 6%) and ovarian (38, 5.2%).

Before the study, the researchers hypothesized that malnutrition could contribute to vitamin D deficiency and therefore expec
'/>"/>

SOURCE Cancer Treatment Centers of America
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
2. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
3. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
4. Allos Therapeutics Initiates Study of PDX in Patients with Cutaneous T-Cell Lymphoma
5. Multiple Myeloma Research Consortium (MMRC) Partners with Novartis to Advance Phase II Study of Deacetylase Inhibitor
6. Potential Safety Issue Identified in Ongoing Phase 2 Clinical Study of HCV-796
7. Study Suggests High-Dose Fish Oil May Significantly Improve Behavior in Children with ADHD
8. MicroDose Announces Positive Results From the QDose Inhaled Insulin Glucose Clamp Study
9. Video: Landmark Study in The Lancet: Patients Treated With Betaseron(R) After First MS Attack Experienced Significant Delay in MS Progression
10. MacroGenics Begins Global Phase 2/3 Protege Study in Recent-onset Type 1 Diabetes Mellitus
11. Sarasotas Roskamp Institute Releases Study Defining a Mechanism for Development of Obesity and the Metabolic Syndrome, Forerunners of Type 2 Diabetes

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/20/2009)...e/ -- Reportlinker.com announces that a new market..., Global Markets for Assisted Reproductive Devi...4742/Global-Markets-for-Assisted-Reproductive-Devi...=pr&utm_campaign=prnewswire ,, Global Mar... Countries in Europe and Japan. This report includ...
(Date:11/20/2009)...irstCall/ -- Cyberonics, Inc. (Nasdaq: CYBX ) tod...xecutive Officer, and Greg Browne, Chief Financial...ffray Health Care Conference in New York on Wednes...ence session and webcast will be audio only and no...ill host a webcast of the presentation live and by...
(Date:11/20/2009)...swire-FirstCall/ -- Soligenix, Inc. (OTC Bulletin ...known as DOR BioPharma, Inc., a late-stage biotech... a consortium to develop thermostable technology t...nes. Soligenix received a $9.4 million grant from ...iseases (NIAID), a division of the National Instit...
Breaking Medicine Technology:Reportlinker Adds Global Markets for Assisted Reproductive Devices 2009 2Cyberonics to Present at 21st Annual Piper Jaffray Health Care Conference 2Soligenix Forms Consortium to Develop Thermostable Technology to Advance RiVax(TM) and Other Rapidly Acting Vaccines 2Soligenix Forms Consortium to Develop Thermostable Technology to Advance RiVax(TM) and Other Rapidly Acting Vaccines 3Soligenix Forms Consortium to Develop Thermostable Technology to Advance RiVax(TM) and Other Rapidly Acting Vaccines 4Soligenix Forms Consortium to Develop Thermostable Technology to Advance RiVax(TM) and Other Rapidly Acting Vaccines 5Soligenix Forms Consortium to Develop Thermostable Technology to Advance RiVax(TM) and Other Rapidly Acting Vaccines 6Blue Shield of California Expands CalPERS NetValue Service Area 52337 1Blue Shield of California Expands CalPERS NetValue Service Area 52337 2Blue Shield of California Expands CalPERS NetValue Service Area 52337 3Free Drug Card Has Saved Washington Residents 242 6 Million 52334 1Free Drug Card Has Saved Washington Residents 242 6 Million 52334 2Young Innovations Inc Board of Directors Declares Quarterly Dividend and Authorizes Share Repurchase Program 52330 1Young Innovations Inc Board of Directors Declares Quarterly Dividend and Authorizes Share Repurchase Program 52330 2Young Innovations Inc Board of Directors Declares Quarterly Dividend and Authorizes Share Repurchase Program 52330 3Young Innovations Inc Board of Directors Declares Quarterly Dividend and Authorizes Share Repurchase Program 52330 4Young Innovations Inc Board of Directors Declares Quarterly Dividend and Authorizes Share Repurchase Program 52330 5Young Innovations Inc Board of Directors Declares Quarterly Dividend and Authorizes Share Repurchase Program 52330 6Young Innovations Inc Board of Directors Declares Quarterly Dividend and Authorizes Share Repurchase Program 52330 7Young Innovations Inc Board of Directors Declares Quarterly Dividend and Authorizes Share Repurchase Program 52330 8
...ics, Inc.,(Nasdaq: PCYC ) today announced that i...calation study to evaluate the safety and tolerabi...nhibitor of Bruton,s tyrosine kinase, or Btk,as a ...refractory B-cell,non-Hodgkin,s lymphoma (NHL). ...sted in humans, and is Pharmacyclics, fourth produ...
...ncy, Binding Capabilities for Antibody Pipeline An...il 9 InNexus Biotechnology Inc. (Toronto Stock Ex...velopment company commercializing the next generat...gy, Dynamic Cross Linking (DXL(TM)), announced tod... its lead preclinical candidate DXL625 (CD20) for ...
Other Medicine Technology:Pharmacyclics Initiates Phase 1 Clinical Trial of Novel Oral Btk Inhibitor for Refractory B-cell Non-Hodgkin's Lymphoma 2Pharmacyclics Initiates Phase 1 Clinical Trial of Novel Oral Btk Inhibitor for Refractory B-cell Non-Hodgkin's Lymphoma 3Pharmacyclics Initiates Phase 1 Clinical Trial of Novel Oral Btk Inhibitor for Refractory B-cell Non-Hodgkin's Lymphoma 4Pharmacyclics Initiates Phase 1 Clinical Trial of Novel Oral Btk Inhibitor for Refractory B-cell Non-Hodgkin's Lymphoma 5AACR Data Highlights InNexus Preclinical Antibody Candidate 2
(Date:11/21/2009)...ilvia Lopez, by her attorney MICHAEL STEWART FRANK...eme Court, New York County, bearing Index # 112888...underwent a routine transesophageal echocardiogram... an HIV infected scope exposing her to HIV. ,...eing discharged from the procedure and arriving ba...
(Date:11/21/2009)...parel company launches men,s lab coats at Medica 2...ente, Calif. (PRWEB) November 21, 2009 -- Medelita...y announced the launch of its men,s lab coats, whi...ational trade fair for the medical industry held i...n,s collection with three varying lab coat styles,...
(Date:11/20/2009)...erstanding Brain Wiring and Diseases ,, WASHING... Schmahmann, Professor of Neurology at Harvard Med...eneral Hospital in Boston, on Thursday, November 1...field of study called "Connectivity" at the launch...is an award-winning leader in the field of the cer...
(Date:11/20/2009)...men in Competitive Re-election Battles Could Be in... Washington, DC (Vocus) November 20, ...ection next year in races deemed to be competitive...t voting for House Speaker Nancy Pelosi’s he...rnational/ O’Leary Report poll. (The Poll ...
(Date:11/20/2009)...wire-USNewswire/ -- Samuel Gladding is no Scrooge,...to be "happy" during the holidays. As a licensed p...ounseling and chair of the Department of Counselin...h shows that it is the pressure to be happy that o...he holidays. ,, That,s why he,s challenging the...
Breaking Medicine News(10 mins):Health News:Patient Files Suit Against St. Vincent's Hospital in New York City as a Result of the Alleged Use by the Hospital of an HIV Infected Device During a Routine Procedure 2Health News:Medelita Introduces Men's Lab Coat Collection 2Health News:Medelita Introduces Men's Lab Coat Collection 3Health News:MINDlink Foundation Launches to Connect the Cerebellum to Cures 2Health News:Just 25% of Voters in Competitive 2010 Senate Races “Much More Likely” to Support Pelosi-Democrats Who Voted for Health Care Bill 2Health News:Just 25% of Voters in Competitive 2010 Senate Races “Much More Likely” to Support Pelosi-Democrats Who Voted for Health Care Bill 3Health News:Why Holidays Don't Have To Be 'Happy' 2
...West Australian scientists have cured mice of a de... Syndrome a breakthrough that could ultimately he...research, published online today in the Journal o...e of Floppy Baby Syndrome a congenital myopathy d...
...es in non-human primates differ from those in huma...Scientists have long noticed a curious phenomenon ...gical disorder known as Alzheimer,s disease, but t... the same protein plaques that are believed by man...
... David Perecman, a NY Personal Injury and ped...nt on the set of an upcoming film as an example fo... May 25, 2009 -- New York personal injury claims ... , ,In the second accident, nine crew members were...
...ted could be sent to manufacturers by month,s end,...ws) -- U.S, health officials reported progress tow...th experts at the U.S. Centers for Disease Control...ne virus," Dr. Anne Schuchat, the CDC,s interim de...
...d by barbecued meats spur new ideas for the summer...s) -- If you,re given the choice between a grilled...emorial Day weekend, go for the veggie. , Eating m...doesn,t mean if you eat well-done steak that you w...
... Trustees representing hospitals from across ...rustee Conferences, which were held in New Orleans...o on April 1-3; and Charlotte on May 6-8. The conf...tals from across the United States attended QHR,s...
Other Medicine News:Health News:Australian team reveals world-first discovery in a 'floppy baby' syndrome 2Health News:Australian team reveals world-first discovery in a 'floppy baby' syndrome 3Health News:Why Chimps, Monkeys Don't Develop Alzheimer's 2Health News:New York Personal Injury Claims Lawyer Warns Pedestrians to Be Aware 2Health News:U.S. Closer to Viable Swine Flu Shot 2Health News:U.S. Closer to Viable Swine Flu Shot 3Health News:U.S. Closer to Viable Swine Flu Shot 4Health News:U.S. Closer to Viable Swine Flu Shot 5Health News:U.S. Closer to Viable Swine Flu Shot 6Health News:U.S. Closer to Viable Swine Flu Shot 7Health News:U.S. Closer to Viable Swine Flu Shot 8Health News:U.S. Closer to Viable Swine Flu Shot 9Health News:U.S. Closer to Viable Swine Flu Shot 10Health News:U.S. Closer to Viable Swine Flu Shot 11Health News:U.S. Closer to Viable Swine Flu Shot 12Health News:U.S. Closer to Viable Swine Flu Shot 13Health News:Skip the Burgers and Throw Some Veggies on the Grill 2Health News:QHR 2009 Regional Trustee Conferences Draw Attendees from Across the Country 2
Universal I/A handpiece - Titanium (Binkhorst Tip)
Universal I/A handpiece - Titanium (Straight Tip, Size: 16g Outer Cannula)
PremierEdge™ Clear Cornea Knives - Parallel Sides
Terry-Schanzlin Astigmatome - Vacuum Speculum
Medicine Products: